Skip to content

Applications of continuous femoral nerve block combined with a variety of analgesia ways after total knee arthroplasty surgery

Applications of continuous femoral nerve block combined with a variety of analgesia ways after total knee arthroplasty surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICC-15006969
Enrollment
Unknown
Registered
2015-08-24
Start date
1990-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total knee arthroplasty surgery

Interventions

1:CFNB
2:parecoxib sodium
3:Intra articular injection
4:parecoxib sodium and intra articular injection

Sponsors

peking university third hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age between 40-80 years; 2. the weight 40-l00 kg; 3. American Society of Anesthesiology Medical Association (American Society of Anesthesiologists, ASA I-II level; 4. of previously healthy or hypertension grade I, and get effective control, peri operative blood pressure not higher than 140 / 90mmHg. Fifthly, diabetes is less than 5 years, without target organ damage and get effective control, enclosed operative glycemic control in less than 10 mmol / L, and a power and with the ability of informed consent.

Exclusion criteria

Exclusion criteria: 1. have significant psychological problems, a history of mental illness, long-term history of chronic pain and take the town for a long time, painkillers, sedatives, anti depression drugs, anti anxiety drug history, NSAIDs drugs, alcohol and drug abuse history; II have asthma or bronchitis, major cardiovascular disease, liver and kidney function is not complete, gastric ulcer history, coagulation dysfunction; 2. to which any kind of drug allergy history; 3. there suffering from limb neuromuscular defect; fifthly, language and communication difficulties; the patients asked to withdraw.

Design outcomes

Primary

MeasureTime frame
VAS score;

Countries

China

Contacts

Public ContactXiangyang Guo
xueling9900@163.com+86 15611908488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026